Viridian Therapeutics
VRDN
VRDN
28 hedge funds and large institutions have $11.9M invested in Viridian Therapeutics in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.07% less ownership
Funds ownership: 1.42% → 1.35% (-0.07%)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Holders
28
Holding in Top 10
1
Calls
$555K
Puts
–
Top Buyers
| 1 | +$82.8K | |
| 2 | +$48.6K | |
| 3 | +$45.4K | |
| 4 |
Squarepoint
New York
|
+$39.3K |
| 5 |
GPFA
Game Plan Financial Advisors
Westlake,
Ohio
|
+$18.9K |
Top Sellers
| 1 | -$563K | |
| 2 | -$36.6K | |
| 3 | -$20K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$19.9K |
| 5 |
Mercer Global Advisors
Denver,
Colorado
|
-$6K |